Showing 17 of 17 recruiting trials for “rare-hepatic-and-biliary-tract-tumor”
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
RecruitingNCT07466602 ↗
cfDNA Methylation for Liver Cancer Recurrence Detection
HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
RecruitingNCT06849180 ↗
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
👨⚕️ Gao-Jun Teng, M.D, Zhongda hospital, Southeast university, Nanjing, China📍 1 site📅 Started Dec 2024View details ↗
Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection
👨⚕️ Warangkana Lapisatepun, MD. PhD., Chiang Mai University📍 1 site📅 Started Nov 2024View details ↗
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
RecruitingNCT06486454 ↗
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RecruitingNCT07337850 ↗
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
👨⚕️ Salah-Eddin SE Al-Batran, Prof. Dr., Frankfurter Institut fuer Klinische Krebsforschung IKF GmbH📍 10 sites📅 Started Aug 2024View details ↗
RecruitingNCT07224750 ↗
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
👨⚕️ Jonathan M Hernandez, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Oct 2022View details ↗
Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer
RecruitingNCT05404347 ↗
NGS in Gallbladder Cancer and Response to Treatment
RecruitingNCT03445585 ↗
Biobank for Cholestatic Liver Diseases.
RecruitingNCT05128890 ↗
Evaluation of Resection Techniques for Pancreatic Tumors
👨⚕️ Alejandro Mejia, M.D., The Liver Institute, Methodist Dallas Medical Center📍 1 site📅 Started Apr 2016View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →